BD PharmingenTM FITC Rat anti-Mouse Ly-6G

Description

Flow cytometric analysis of expression of Ly-6G on bone-marrow leukocytes. BALB/c bone-marrow cell suspensions were stained with either FITC Rat Anti-Mouse Ly-6G Cat. No. 551460/561105, dashed line histograms or FITC Rat IgG2a, kappa Isotype Control Cat. No. 553929, shaded histograms , in the presence of Purified Rat Anti-Mouse CD16/CD32 Mouse BD Fc Block , Cat. No. 553141/553142 . Non-viable leukocytes were excluded by staining with propidium iodide, and leukocyte subsets were distinguished by their light scatter profiles. Left panel displays lymphoid and erythroid cells, and the right panel displays myeloid cells. Flow cytometry was performed on a FACSCalibur. Flow cytometric analysis of expression of Ly-6G on bone-marrow leukocytes. BALB/c bone-marrow cell suspensions were stained with either FITC Rat Anti-Mouse Ly-6G Cat. No. 551460/561105, dashed line histograms or FITC Rat IgG2a, kappa Isotype Control Cat. No. 553929, shaded histograms , in the presence of Purified Rat Anti-Mouse CD16/CD32 Mouse BD Fc Block , Cat. No. 553141/553142 . Non-viable leukocytes were excluded by staining with propidium iodide, and leukocyte subsets were distinguished by their light scatter profiles. Left panel displays lymphoid and erythroid cells, and the right panel displays myeloid cells. Flow cytometry was performed on a FACSCalibur. Flow cytometric analysis of expression of Ly-6G on bone-marrow leukocytes. BALB/c bone-marrow cell suspensions were stained with either FITC Rat Anti-Mouse Ly-6G Cat. No. 551460/561105, dashed line histograms or FITC Rat IgG2a, kappa Isotype Control Cat. No. 553929, shaded histograms , in the presence of Purified Rat Anti-Mouse CD16/CD32 Mouse BD Fc Block , Cat. No. 553141/553142 . Non-viable leukocytes were excluded by staining with propidium iodide, and leukocyte subsets were distinguished by their light scatter profiles. Left panel displays lymphoid and erythroid cells, and the right panel displays myeloid cells. Flow cytometry was performed on a FACSCalibur. Show More Flow cytometric analysis of expression of Ly-6G on bone-marrow leukocytes. BALB/c bone-marrow cell suspensions were stained with either FITC Rat Anti-Mouse Ly-6G Cat. No. 551460/561105, dashed line histograms or FITC Rat IgG2a, kappa Isotype Control Cat. No. 553929, shaded histograms , in the presence of Purified Rat Anti-Mouse CD16/CD32 Mouse BD Fc Block , Cat. No. 553141/553142 . Non-viable leukocytes were excluded by staining with propidium iodide, and leukocyte subsets were distinguished by their light scatter profiles. Left panel displays lymphoid and erythroid cells, and the right panel displays myeloid cells. Flow cytometry was performed on a FACSCalibur. Show More Flow cytometric analysis of expression of Ly-6G on bone-marrow leukocytes. BALB/c bone-marrow cell suspensions were stained with either FITC Rat Anti-Mouse Ly-6G Cat. No. 551460/561105, dashed line histograms or FITC Rat IgG2a, kappa Isotype Control Cat. No. 553929, shaded histograms , in the presence of Purified Rat Anti-Mouse CD16/CD32 Mouse BD Fc Block , Cat. No. 553141/553142 . Non-viable leukocytes were excluded by staining with propidium iodide, and leukocyte subsets were distinguished by their light scatter profiles. Left panel displays lymphoid and erythroid cells, and the right panel displays myeloid cells. Flow cytometry was performed on a FACSCalibur. Flow cytometric analysis of expression of Ly-6G on bone-marrow leukocytes. BALB/c bone-marrow cell suspensions were stained with either FITC Rat Anti-Mouse Ly-6G Cat. No. 551460/561105, dashed line histograms or FITC Rat IgG2a, kappa Isotype Control Cat. No. 553929, shaded histograms , in the presence of Purified Rat Anti-Mouse CD16/CD32 Mouse BD Fc Block , Cat. No. 553141/553142 . Non-viable leukocytes were excluded by staining with propidium iodide, and leukocyte subsets were distinguished by their light scatter profiles. Left panel displays lymphoid and erythroid cells, and the right panel displays myeloid cells. Flow cytometry was performed on a FACSCalibur.